1437786 - Immune Design Corp. - SEC Form 4 Insider Trading Screener

Financial - Security and Commodity Brokers - Investment Advice - IMDZ (1437786)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
43 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S6-4+0-6+0

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2018-12-04
IMDZBvf Partners L P/il10%S - Sale$1.83-902,000370,391-71%-$1,653,907
2018-11-07
IMDZTer Meulen Jan HenrikChief Scientific OfficerA - Grant$0.00+23,36262,396+60%+$0
2018-11-07
IMDZBrady Stephen REVP, Strategy, FinanceA - Grant$0.00+29,95377,115+64%+$0
2018-11-07
IMDZYurasov SergeySVP, Clinic. Devel., CMOA - Grant$0.00+29,95357,278+110%+$0
A
2018-01-08
IMDZGuthart Leo10%P - Purchase$3.90+20,0005,664,7390%+$78,000
D
2018-01-04
IMDZGombotz WayneChief Development OfficerA - Grant$0.00+16,00037,068+76%+$0
D
2018-01-05
IMDZGombotz WayneChief Development OfficerS - Sale+OE$4.17-1,98637,068-5%-$8,282
D
2018-01-04
IMDZPaya Carlos VPres, CEOA - Grant$0.00+46,500106,590+77%+$0
D
2018-01-05
IMDZPaya Carlos VPres, CEOS - Sale+OE$4.17-7,970106,590-7%-$33,247
D
2018-01-04
IMDZTer Meulen Jan HenrikChief Scientific OfficerA - Grant$0.00+18,00039,034+86%+$0
D
2018-01-05
IMDZTer Meulen Jan HenrikChief Scientific OfficerS - Sale+OE$4.17-1,98639,034-5%-$8,282
D
2018-01-04
IMDZBrady Stephen REVP, Strategy, FinanceA - Grant$0.00+20,00047,162+74%+$0
D
2018-01-05
IMDZBrady Stephen REVP, Strategy, FinanceS - Sale+OE$4.17-3,32847,162-7%-$13,885
A
2018-01-05
IMDZYurasov SergeySVP, Clinic. Devel., CMOS - Sale$4.17-67527,325-2%-$2,816
D
2018-01-04
IMDZYurasov SergeySVP, Clinic. Devel., CMOA - Grant$0.00+22,00027,325+413%+$0
D
2018-01-04
IMDZYurasov SergeySVP, Clinic. Devel., CMOS - Sale+OE$4.17-67527,325-2%-$2,816
2017-11-02
IMDZColeman Lewis WDirP - Purchase$4.50+50,000178,000+39%+$225,000
2017-10-30
IMDZBerger Franklin MDirP - Purchase$4.58+25,00075,000+50%+$114,375
2017-10-27
IMDZColeman Lewis WDirP - Purchase$4.07+65,000128,000+103%+$264,752
A
2017-10-27
IMDZGuthart Leo10%P - Purchase$4.10+2,439,0005,644,739+76%+$9,999,900
A
2017-10-31
IMDZGuthart Leo10%G - Gift$0.00-2,5005,644,7390%-$0
2017-10-27
IMDZColumn Group L P10%P - Purchase$4.10+2,681,0006,642,942+68%+$10,992,100
2017-10-27
IMDZSvennilson PeterDir, 10%P - Purchase$4.10+2,681,0006,642,942+68%+$10,992,100
2017-10-25
IMDZBerger Franklin MDirP - Purchase$4.26+25,00050,000+100%+$106,620
AM
2017-10-20
IMDZGuthart Leo10%P - Purchase$4.65+60,0003,208,239+2%+$278,991
AM
2017-10-18
IMDZGuthart Leo10%P - Purchase$6.09+10,0003,148,2390%+$60,938
A
2017-09-18
IMDZGuthart Leo10%P - Purchase$9.70+10,0003,138,2390%+$97,000
D
2017-08-01
IMDZGombotz WayneChief Development OfficerM - OptEx$1.31+10,00023,054+77%+$13,100
D
2017-08-01
IMDZGombotz WayneChief Development OfficerS - Sale+OE$11.43-10,00023,054-30%-$114,336
M
2017-07-10
IMDZColeman Lewis WDirP - Purchase$9.05+12,00063,000+24%+$108,600
M
2017-07-06
IMDZColeman Lewis WDirP - Purchase$9.27+8,00051,000+19%+$74,150
M
2017-05-09
IMDZGuthart Leo10%P - Purchase$6.09+30,0003,128,239+1%+$182,607
D
2017-01-04
IMDZTer Meulen Jan HenrikChief Scientific OfficerA - Grant$0.00+12,00023,020+109%+$0-1+7+2
D
2017-01-04
IMDZTer Meulen Jan HenrikChief Scientific OfficerS - Sale+OE$5.35-98023,020-4%-$5,243-1+7+2
D
2017-01-04
IMDZGombotz WayneChief Development OfficerA - Grant$0.00+12,00023,054+109%+$0-1+7+2
D
2017-01-04
IMDZGombotz WayneChief Development OfficerS - Sale+OE$5.35-98023,054-4%-$5,243-1+7+2
D
2017-01-04
IMDZPaya Carlos VPres, CEOA - Grant$0.00+36,00068,060+112%+$0-1+7+2
D
2017-01-04
IMDZPaya Carlos VPres, CEOS - Sale+OE$5.35-3,94068,060-5%-$21,079-1+7+2
D
2017-01-04
IMDZBrady Stephen REVP, Strategy, FinanceA - Grant$0.00+15,00030,490+97%+$0-1+7+2
D
2017-01-04
IMDZBrady Stephen REVP, Strategy, FinanceS - Sale+OE$5.35-1,64230,490-5%-$8,785-1+7+2
D
2017-01-04
IMDZYurasov SergeySVP, Clinic. Devel., CMOA - Grant$0.00+6,0006,000New+$0-1+7+2
2016-12-22
IMDZColeman Lewis WDirS - Sale$6.20-10,00043,000-19%-$62,039-11-20-17
2016-12-16
IMDZBerger Franklin MDirS - Sale$6.55-50,00025,000-67%-$327,330-7-6-24
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top